Acetylation of FOXO3a transcription factor in response to imatinib of chronic myeloid leukemia

Leukemia

Volumn 23, Issue 2, 2009, Pages 405-406

  Corrado, P ^a   Mancini, M ^a   Brusa, G ^a   Petta, S ^a   Martinelli, G ^a   Barbieri, E ^a   Santucci, M A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; IMATINIB; TRANSCRIPTION FACTOR FKHRL1;

ACETYLATION; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; CANCER RESISTANCE; CELL CLONE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG RESPONSE; ENZYME INHIBITION; GENETIC TRANSCRIPTION; LETTER; MOUSE; NONHUMAN; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 60149092466     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.186     Document Type: Letter

References (8)

1. Calnan DR, Brunet A. The FoxO code. Oncogene 2008; 27: 2276-2288.
2. Tsai K-L, Sun Y-J, Huang C-Y, Yang M-C H, Hsiao C-D. Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification. Nucleic Acids Res 2007; 35: 6984-6994.
3. Vogt PK, Jiang H, Aoki M. Triple layer control. Phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 2005; 4: 908-913.
4. Matsuzaki H, Daitoku H, Hatta M, Aoyama H, Yoshimochi K, Fukamizu A. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc Natl Acad Sci USA 2005; 102: 11278-11283.
5. Komatsu N, Watanabe T, Uchida M, Mori M, Kirito K, Kikuchi S et al. A member of forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells. J Biol Chem 2003; 278: 6411-6419.
6. Essafi A, Fernàndez de mattos S, Hassen YA, Soeiro I, Mufti GJ, Thomas NS et al. Direct transcriptional regulation of Bim by Foxo3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 2005; 24: 2317-2329.
7. Mahmud DL, G-Amlak M, Deb DK, Platanias LC, Uddin S, Wickrema A. Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells. Oncogene 2002; 21: 1556-1562.
8. Mancini M, Brusa G, Zuffa E, Corrado P, Martinelli G, Grafone T et al. Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI-606. Leuk Res 2007; 31: 979-987.